{"id":"https://openalex.org/W2047485232","doi":"https://doi.org/10.5639/gabij.2014.0302.018","title":"Biosimilars naming, label transparency and authority of choice \u2013 survey findings among European physicians","display_name":"Biosimilars naming, label transparency and authority of choice \u2013 survey findings among European physicians","publication_year":2014,"publication_date":"2014-06-11","ids":{"openalex":"https://openalex.org/W2047485232","doi":"https://doi.org/10.5639/gabij.2014.0302.018","mag":"2047485232"},"language":"en","primary_location":{"id":"doi:10.5639/gabij.2014.0302.018","doi":"https://doi.org/10.5639/gabij.2014.0302.018","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2014.0302.018","pdf_url":"http://gabi-journal-net.server1.ech.be/wp-content/uploads/GJ-2014-2-p58-62-OriginalResearch-ODolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://gabi-journal-net.server1.ech.be/wp-content/uploads/GJ-2014-2-p58-62-OriginalResearch-ODolinar.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031560530","display_name":"Richard O. Dolinar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard O Dolinar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046602656","display_name":"Michael S Reilly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael S Reilly","raw_affiliation_strings":["Alliance for Safe Biologic Medicines , PO Box 3691 Arlington , VA 22203 , USA","Executive Director, Alliance for Safe Biologic Medicines, PO Box 3691 Arlington, VA 22203, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance for Safe Biologic Medicines , PO Box 3691 Arlington , VA 22203 , USA","institution_ids":[]},{"raw_affiliation_string":"Executive Director, Alliance for Safe Biologic Medicines, PO Box 3691 Arlington, VA 22203, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7073,"has_fulltext":true,"cited_by_count":44,"citation_normalized_percentile":{"value":0.94081421,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"3","issue":"2","first_page":"58","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-nomenclature","display_name":"drug names","score":0.7519999742507935},{"id":"https://openalex.org/keywords/biological-medicines","display_name":"biological medicines","score":0.5519999861717224},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.32199999690055847},{"id":"https://openalex.org/keywords/prescriber-attitudes","display_name":"prescriber attitudes","score":0.5979999899864197},{"id":"https://openalex.org/keywords/european-physicians","display_name":"European physicians","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9466382265090942},{"id":"https://openalex.org/C2780233690","wikidata":"https://www.wikidata.org/wiki/Q535347","display_name":"Transparency (behavior)","level":2,"score":0.8385886549949646},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5168783664703369},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.3938550651073456},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3284669518470764},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.13351503014564514},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.12975814938545227},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09163540601730347}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5639/gabij.2014.0302.018","doi":"https://doi.org/10.5639/gabij.2014.0302.018","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2014.0302.018","pdf_url":"http://gabi-journal-net.server1.ech.be/wp-content/uploads/GJ-2014-2-p58-62-OriginalResearch-ODolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.5639/gabij.2014.0302.018","doi":"https://doi.org/10.5639/gabij.2014.0302.018","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2014.0302.018","pdf_url":"http://gabi-journal-net.server1.ech.be/wp-content/uploads/GJ-2014-2-p58-62-OriginalResearch-ODolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2047485232.pdf","grobid_xml":"https://content.openalex.org/works/W2047485232.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2110327661","https://openalex.org/W2312387566","https://openalex.org/W2313576597","https://openalex.org/W2316911410","https://openalex.org/W2321648386","https://openalex.org/W4206608217","https://openalex.org/W4253079720"],"related_works":["https://openalex.org/W2617598105","https://openalex.org/W2500368767","https://openalex.org/W2570158360","https://openalex.org/W3168037041","https://openalex.org/W4240869355","https://openalex.org/W2189145160","https://openalex.org/W4249294001","https://openalex.org/W3110543219","https://openalex.org/W4238350085","https://openalex.org/W2329939481"],"abstract_inverted_index":{"Introduction:":[0],"A":[1],"survey":[2],"of":[3,6,11,41],"the":[4,16,49],"views":[5],"European":[7],"physicians":[8],"on":[9],"familiarity":[10],"biosimilar":[12],"medicines":[13],"has":[14],"demonstrated":[15],"need":[17],"for":[18,31],"distinguishable":[19],"non-proprietary":[20],"names":[21],"to":[22,25,51],"be":[23],"given":[24],"all":[26],"biologicals.":[27],"Methods:":[28],"The":[29],"Alliance":[30],"Safe":[32],"Biologic":[33],"Medicines":[34],"recruited":[35],"470":[36],"prescribers":[37],"with":[38],"clinical":[39],"experience":[40],"biologicals":[42],"in":[43],"France,":[44],"Germany,":[45],"Italy,":[46],"Spain":[47],"and":[48],"UK":[50],"answer":[52],"questions":[53],"relating":[54]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}